Figure 3 - uploaded by Aisling O'Hara
Content may be subject to copyright.
S3 Characterization of Treg cells during multiple TH1 infections. (A) BrdU incorporation by T-bet + Treg cells was measured following T. gondii infection by flow cytometry, LPL shown from naïve and day 9 infected mice, (gated on Foxp3 + , CD4 + , live/dead-cells). (B) Treg cell expression of Ki67 following oral T. gondii infection (gated on Foxp3 + , CD4 + , live cells), day 9 shown. (C-F) WT or DEREG mice were infected orally with 10 cysts of ME49. Two days postinfection, DT was administrated daily until day 9 to deplete CD4 + Foxp3 + Treg cells. (C) Treg cell frequencies in spleen, MLN and LP compartments at day 6 postinfection (day 4 of DT treatment). (D) Cells were stained for TCR-β, CD4, CD8, Foxp3, and Ki67 to determine effector T cell proliferation after Treg cell depletion.

S3 Characterization of Treg cells during multiple TH1 infections. (A) BrdU incorporation by T-bet + Treg cells was measured following T. gondii infection by flow cytometry, LPL shown from naïve and day 9 infected mice, (gated on Foxp3 + , CD4 + , live/dead-cells). (B) Treg cell expression of Ki67 following oral T. gondii infection (gated on Foxp3 + , CD4 + , live cells), day 9 shown. (C-F) WT or DEREG mice were infected orally with 10 cysts of ME49. Two days postinfection, DT was administrated daily until day 9 to deplete CD4 + Foxp3 + Treg cells. (C) Treg cell frequencies in spleen, MLN and LP compartments at day 6 postinfection (day 4 of DT treatment). (D) Cells were stained for TCR-β, CD4, CD8, Foxp3, and Ki67 to determine effector T cell proliferation after Treg cell depletion.

Source publication
Article
Full-text available
Interleukin (IL)–27 is a heterodimeric cytokine with potent inhibitory properties. Thus, mice that lack IL–27–mediated signaling develop exaggerated inflammatory responses during toxoplasmosis as well as other infections or autoimmune processes. While regulatory T (Treg) cells are critical to limit inflammation, their role during toxoplasmosis is c...

Similar publications

Article
Full-text available
Background Recently, immunotherapy with anti-PD-1 antibodies has shown clinical benefit in recurrent Small Cell Lung Cancer (SCLC). Since anti-PD-1 re-activates anti-tumor Cytotoxic T Lymphocyte (CTL) responses, it is crucial to understand the mechanisms regulating HLA class I, and PD-L1 expression in HLA-negative SCLC. Here we addressed the role o...
Article
Full-text available
Background: Malignancies represent the third leading cause of post-transplant mortality worldwide. The main challenge for transplant physicians is a timely diagnosis of this condition. The aim of the study was to identify a soluble diagnostic marker for monitoring the development of post-transplant malignancies. Methods: This is a multicentre, o...
Article
Full-text available
Fibromyalgia (FM) is a complex, multi-symptom condition that predominantly affects women. The majority of those affected are unlikely to gain significant symptomatic control from the few treatments that are approved for FM. In this 10-week, single-blind, crossover trial we tested the immune effects of eight weeks of oral administration of low-dose...
Preprint
Full-text available
Abdominal Aortic Aneurysm (AAA) is a vascular disease, where aortic wall degradation is mediated by accumulated immune cells. Though cytokines regulate the inflammatory milieu within the aortic wall, their contribution to AAA through distant alterations, particularly in the control of hematopoietic stem cells proliferation and myeloid cell differen...